continuation of our research on discovery of novel heterocyclic scaffolds from 1,3,5-triazine, present study deals with design and development of some novel di- and tri-substituted 1,3,5-triazine derivatives. The synthesis of title analogues were accomplished by SNAr reaction and subsequently underwent rigorous antibacterial screening against a panel of representative Gram-negative and Gram-positive bacteria
由于大量产生抗药性微
生物,迫切需要开发新型
化学治疗剂。在继续我们从
1,3,5-三嗪发现新型杂环支架的研究的过程中,本研究涉及一些新型的二和三取代的
1,3,5-三嗪衍
生物的设计和开发。标题类似物的合成通过SNAr反应完成,然后针对一组代表性的革兰氏阴性和革兰氏阳性细菌进行严格的抗菌筛选。筛选结果表明,微小的结构变异可能会引起活性的急剧变化。胺桥和
哌嗪被称为
生物活性的产生和升级所必需的关键结构片段。